FDA and Chevron Deference: A Case Review (Open Access)

Food and Drug Law Institute (FDLI)·Dec 15

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A case review is available regarding the FDA and Chevron deference. The Chevron deference appears to have been overturned, potentially impacting various areas, including the FDA and healthcare regulation. The implications of this development are being explored, with some outlets considering the effects on physicians, Congress, and the regulatory landscape.

Full coverage

FDA v. Alliance for Hippocratic Medicine: Recapping the Supreme Court’s Oral Argument

Georgetown University·Apr 10

Chevron Gets the Headlines, But State Farm May Be More Important

Legal Planet·Mar 25

View original report at Food and Drug Law Institute (FDLI) ↗

Fetching the latest headlines…

FDA and Chevron Deference: A Case Review (Open Access)

Full coverage

With Chevron Deference Ended, What Happens Next?

The Major Questions Doctrine: Unfounded, Unbounded, and Confounded

Chevron Overturned: FDA at a Crossroads, But How Will Physicians Be Affected?

Congress Struggling with Post-Chevron World

Chevron’s Latest Step, by Nicholas Bednar

Drilling Down on Loper Bright and Health Care Regulation

FDA v. Alliance for Hippocratic Medicine: Recapping the Supreme Court’s Oral Argument

Chevron Gets the Headlines, But State Farm May Be More Important